等待开盘 09-22 09:30:00 美东时间
-0.045
-1.23%
Arcadia Biosciences (NASDAQ:RKDA) reported quarterly losses of $(3.26) per share which missed the analyst consensus estimate of $(0.79) by 312.66 percent. This is a 517.95 percent decrease over earnings of $0.78 per
08-15 04:39
Arcadia Biosciences reported Q2 2025 results with total revenues up 11% year-over-year, driven by Zola coconut water revenues rising 24%. The company received 2.7 million ABVE shares as partial repayment of a $6 million note and eliminated $1M in liabilities. Gross margins exceeded 30% for ten straight quarters. Operating expenses remained low despite $700K in transaction fees. Arcadia continues pursuing its business combination with Roosevelt Re...
08-14 20:30
Arcadia Biosciences ( ($RKDA) ) has shared an announcement. On May 14, 2024, Ar...
05-17 05:50
Arcadia Biosciences (NASDAQ:RKDA) reported quarterly earnings of $1.90 per share which beat the analyst consensus estimate of $(0.76) by 350 percent. This is a 206.74 percent increase over losses of $(1.78) per share
05-08 21:35
Companies Reporting Before The Bell • Sempra (NYSE:SRE) is likely to report qua...
05-08 16:33
Companies Reporting Before The Bell • Star Equity Hldgs (NASDAQ:STRR) is projec...
03-20 16:32
Arcadia Biosciences (NASDAQ:RKDA) is scheduled to announce Q4 earnings results on Thursday, March 20th, after market close. The consensus EPS Estimate is -$0.89 (+57.6% Y/Y) and the consensus Revenue ...
03-20 05:35
NEW YORK, Feb. 15, 2025 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS...
02-16 02:00
北京时间2025年01月07日02时42分,海恩时富(HAIN.us)股票出现异动,股价大幅下挫5.01%。截至发稿,该股报5.88美元/股,成交量52.79...
01-07 02:42